Moderna
MRNA
#1197
Rank
S$20.56 B
Marketcap
$53.44
Share price
-5.62%
Change (1 day)
-43.99%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: S$20.56 Billion

As of November 2024 Moderna has a market cap of S$20.56 Billion. This makes Moderna the world's 1197th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024S$20.56 B-58.94%
2023S$50.07 B-45.87%
2022S$92.50 B-33.55%
2021S$139.21 B154.55%
2020S$54.69 B516.25%
2019S$8.87 B29.38%
2018S$6.85 B

End of Day market cap according to different sources

On Nov 13th, 2024 the market cap of Moderna was reported to be:

S$21.78 Billion
by Nasdaq info icon info icon
S$21.78 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
S$0.13 B-99.36%๐Ÿ‡บ๐Ÿ‡ธ USA
S$334.31 B 1,525.80%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.11 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
S$44.69 B 117.36%๐Ÿ‡บ๐Ÿ‡ธ USA
S$278.65 B 1,255.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$3.57 B-82.61%๐Ÿ‡บ๐Ÿ‡ธ USA
S$491.29 B 2,289.18%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.00 B-80.54%๐Ÿ‡บ๐Ÿ‡ธ USA